RUNX3 Expression in Primary and Metastatic Pancreatic Cancer

Journal of Clinical Pathology - United Kingdom
doi 10.1136/jcp.2003.013011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With Nab-Paclitaxel and Gemcitabine

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2017English

Therapeutic Strategies in Primary and Metastatic Liver Cancer

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1987English

Pancreatic Cancer: Planning Ahead for Metastatic Spread

Cancer Cell
Cancer ResearchOncologyCell Biology
2016English

Comparison Study of E-Cadherin Expression in Primary Breast Cancer and Its Corresponding Metastatic Lymph Node

Journal of Cytology & Histology
2012English

Cross-Over Comparison and New Chemotherapy Regimens in Metastatic Pancreatic Cancer

Memo - Magazine of European Medical Oncology
OncologyHematology
2017English

Role of Fibrillar Tenascin-C in Metastatic Pancreatic Cancer

International Journal of Oncology
Cancer ResearchOncology
2009English

Survivin Expression and Serum Levels in Pancreatic Cancer

World Journal of Surgical Oncology
SurgeryOncology
2015English

RUNX3 Gene in Renal Cell Cancer

International Journal of Molecular and Immuno Oncology
2018English

Inhibition of the Growth and Metastasis of Human Colon Cancer by Restoration of RUNX3 Expression in Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy